Funded Tech Companies
Clene Nanomedicine
Clene Nanomedicine, operating out of Salt Lake City, has financial backing from Kensington Capital Partners and private investors.
Company Overview
Company Name
Clene Nanomedicine
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
6550 South Millrock Dr. G50
Salt Lake City, UT 84121
USA
Salt Lake City, UT 84121
USA
Phone
Website
Email Address
Company Background Information
Overview
Clene Nanomedicine, Inc. is a privately-held, clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally-administered neurotherapeutic drugs.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/21/2026
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Etherington
Chief Financial Officer
Matthew Gardner
Chief Medical Officer
Robert Glanzman
Chief Scientific Officer
Mark Mortenson
VP - Bus. Development
Michael Hotchkin
Company Investors
- Kensington Capital Partners
- Private Investors (David Matlin)
Browse more funded tech companies:
Clementia Pharmaceuticals | Cleo
Share this article
About Our VC Funding Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs